The National Psoriasis Foundation psoriasis treatment targets in real‐world patients: prevalence and association with patient‐reported outcomes in the Corrona Psoriasis Registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The National Psoriasis Foundation psoriasis treatment targets in real‐world patients: prevalence and association with patient‐reported outcomes in the Corrona Psoriasis Registry

Published:2020-06-09 Issue:9 Volume:34 Page:2051-2058
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Merola J.F.¹²^ORCID,Perez Chada L.M.¹^ORCID,Siegel M.³,Bagel J.⁴,Evans C.⁵,Lockshin B.⁶,Mason M.⁷,Guo N.⁷,McLean R.R.⁷,Greenberg J.D.⁷⁸,Van Voorhees A.S.⁹

Affiliation:

1. Department of Dermatology Brigham and Women's Hospital Harvard Medical School Boston MA USA

2. Department of Medicine Division of Rheumatology Brigham and Women's Hospital Harvard Medical School Boston MA USA

3. National Psoriasis Foundation Portland OR USA

4. Psoriasis Treatment Center of Central New Jersey East Windsor NJ USA

5. Evans Dermatology Partners Austin TX USA

6. DermAssociates Silver Spring MD USA

7. Corrona LLC Waltham MA USA

8. NYU School of Medicine New York NY USA

9. Eastern Virginia Medical School Norfolk VA USA

Funder

AbbVie

Boehringer Ingelheim

Celgene

Valeant Pharmaceuticals International

Merck

Eli Lilly and Company

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16274

Reference36 articles.

1. Psoriasis prevalence among adults in the United States

2. Burden of Disease: Psoriasis and Psoriatic Arthritis

3. Quality of Life in Patients with Psoriasis: A Systematic Literature Review

4. Determinants of quality of life in patients with psoriasis: A study from the US population

5. Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFN-γ, IL-17A, IL-4, and IL-13: Potential Biomarkers for Prediction of the Effectiveness of Biologics in Psoriasis Patients;Biomedicines;2024-05-17

2. Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies;Dermatology and Therapy;2024-03-23

3. Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis;Journal of the European Academy of Dermatology and Venereology;2023-09-21

4. Reaching Treatment Goals in Psoriasis with Conventional Systemic Drugs: How Long Are We Willing to Wait?;Dermatology;2021-06-09

5. Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study;American Journal of Clinical Dermatology;2021-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3